First Horizon Advisors’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
OAG
HL
First Horizon Advisors's GMAB Position: Q2 2025 in Review
First Horizon Advisors reduced its Genmab (GMAB) stake by 8.5% in Q2 2025, selling an estimated $1.19K and leaving 625 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.
First Horizon Advisors first reported a position in GMAB in Q1 2020 and has held it in 20 quarters since. The position peaked at $61K in Q3 2021. 218 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.
- First Horizon Advisors held 625 shares of Genmab worth $12.9K as of Q2 2025.
- First Horizon Advisors sold 58 Genmab shares in Q2 2025, an estimated $1.19K.
- Genmab made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1580 holding.
- First Horizon Advisors first reported a position in Genmab in Q1 2020 and has held it in 20 quarters since.
- First Horizon Advisors's Genmab position peaked at $61K in Q3 2021.
- 218 funds tracked by Wall St. Rank held Genmab as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.